
Decoding Biotech and the Impact of AI on Healthcare
07/23/24 • 18 min
Explore the growth and achievements of the biotech industry over the years as Yaron Werber, Managing Director, Equity Research, TD Cowen, speaks with host Amy Van Arnhem, Managing Director and Head of Canada Senior Relationship Management, TD Securities. Together, they look ahead to the impact AI could have on healthcare, M&A activity, and the unique characteristics of leading markets in the U.S., Europe, China, and Japan.
For deeper insights with guests from leading biotechnology companies, tune in to Yaron Werber's podcast series, Biotech Decoded.
This podcast was recorded on July 15, 2024.
For relevant disclosures, visit: tdsecurities.com/ca/en/legal#PodcastDisclosure. To learn more about TD Securities, visit us at tdsecurities.com or follow us on LinkedIn @tdsecurities.
Explore the growth and achievements of the biotech industry over the years as Yaron Werber, Managing Director, Equity Research, TD Cowen, speaks with host Amy Van Arnhem, Managing Director and Head of Canada Senior Relationship Management, TD Securities. Together, they look ahead to the impact AI could have on healthcare, M&A activity, and the unique characteristics of leading markets in the U.S., Europe, China, and Japan.
For deeper insights with guests from leading biotechnology companies, tune in to Yaron Werber's podcast series, Biotech Decoded.
This podcast was recorded on July 15, 2024.
For relevant disclosures, visit: tdsecurities.com/ca/en/legal#PodcastDisclosure. To learn more about TD Securities, visit us at tdsecurities.com or follow us on LinkedIn @tdsecurities.
Previous Episode

Cowen Acquisition: Unleashing New Opportunities Ahead
To commemorate the one-year anniversary of the Cowen acquisition, Riaz Ahmed, President and CEO, TD Securities, and Jeff Solomon, President, TD Cowen and Vice Chair, TD Securities, return to Viewpoint with host, Amy Van Arnhem, Managing Director and Head of Canada Senior Relationship Management, TD Securities, exploring the integration and ongoing growth potential for clients and colleagues. From fostering a culture of collaboration to enhancing global capabilities, Riaz and Jeff share their perspectives on the transformative journey and the exciting opportunities it presents.
This podcast was recorded on April 9, 2024.
For relevant disclosures, visit: tdsecurities.com/ca/en/legal#PodcastDisclosure. To learn more about TD Securities, visit us at tdsecurities.com or follow us on LinkedIn @tdsecurities.
Next Episode

Disrupt or Be Disrupted: Navigating Industry Shifts in Investment Banking
Join Larry Wieseneck, Vice Chair and Head of Corporate and Investment Banking, TD Securities, and Peter Haynes, Managing Director and Head of Index and Market Structure Research, TD Securities, for a deep dive into the evolving world of investment banking. In this episode, we explore the role of capital in determining market positions, navigating the dichotomy of disruptors versus those at risk of disruption, and the unexpected appeal of traditional sectors in the tech-driven economy. Listen in to gain valuable perspectives on these transformative themes.
This podcast was recorded on August 20, 2024.
For relevant disclosures, visit: tdsecurities.com/ca/en/legal#PodcastDisclosure. To learn more about TD Securities, visit us at tdsecurities.com or follow us on LinkedIn @tdsecurities.
If you like this episode you’ll love
Episode Comments
Generate a badge
Get a badge for your website that links back to this episode
<a href="https://goodpods.com/podcasts/viewpoint-a-td-securities-podcast-432667/decoding-biotech-and-the-impact-of-ai-on-healthcare-63404792"> <img src="https://storage.googleapis.com/goodpods-images-bucket/badges/generic-badge-1.svg" alt="listen to decoding biotech and the impact of ai on healthcare on goodpods" style="width: 225px" /> </a>
Copy